Quantcast

Latest pharmaceutical industry Stories

2014-10-20 20:25:49

LONDON, Oct. 20, 2014 /PRNewswire/ -- Report DetailsTreatments for nausea and vomiting - explore business trends, R&D, and revenue forecastsWhat's the future of treating nausea and vomiting? For those medicines you get sales predictions, also exploring research and development. Those treatments hold high potential. There you assess results, progress, therapies, and opportunities.Visiongain's new report forecasts those revenues to 2024 at overall world market, submarket, product,...

2014-10-20 20:24:32

LONDON, Oct. 20, 2014 /PRNewswire/ -- Future Prospects for Leading Companies Report DetailsDermatological drugs - new study showing you trends, R&D progress, and predicted revenuesWhere's the dermatological drugs market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.Our 272-page report provides 169 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future...

2014-10-20 20:24:18

LONDON, Oct. 20, 2014 /PRNewswire/ -- Report DetailsPre-filled syringes and related devices - discover leading companies' revenue prospectsHow are companies in the pre-filled syringe industry performing? Visiongain's report gives you data, analysis and discussions for producers of those drug delivery devices.Our updated study lets you assess companies in the pre-filled (ready-to-fill) syringe industry and market, showing you their prospects to 2024. There you see financial results,...

2014-10-20 16:27:30

INDIANAPOLIS, Oct. 20, 2014 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2014 of $0.49 per share on outstanding common stock. The dividend is payable December 10, 2014 to shareholders of record at the close of business on November 14, 2014. Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a...

2014-10-20 08:33:33

LONDON, October 20, 2014 /PRNewswire/ -- Richmond Pharmacology has extended its capacity with an additional six-bed facility dedicated to screening and out-patient procedures for early phase studies in patients, complementing its existing 68-bed facility within Croydon University Hospital. (Photo: http://photos.prnewswire.com/prnh/20141013/709417-a ) (Photo: http://photos.prnewswire.com/prnh/20141013/709417-b ) The new facility is adaptable to...

2014-10-20 08:32:49

AACHEN, Germany, October 20, 2014 /PRNewswire/ -- Sascha Becker will be appointed to the Executive Board of the pharmaceutical company Gruenenthal and take over the finance unit as Group Chief Financial Officer in the first quarter of 2015. Since 2003, Sascha Becker (43) has been working for Merck and is currently CFO of the biopharmaceutical division of Merck Serono with an annual turnover of 6.3 million Euros and is responsible for 10,000 employees. At Gruenenthal, he will...

2014-10-20 08:31:47

ALBANY, N.Y., Oct. 20, 2014 /PRNewswire/ -- Pharmaceutic Labs announces the opening of its specialty CGMP pharmaceutical outsourcing facility in Albany, NY for admixing, compounding, drug shortages and clinical studies and trials. The company meets and/or exceeds the FDA standards for safety and quality, using 21 CFR Part 210 and 21 CFR Part 211. The 10,000 square foot outsourcing facility was designed to provide the highest levels of quality assurance and quality control. The...

2014-10-17 23:04:17

Medrio is pleased to announce that Atlantic Research Group is its newest partner. San Francisco, California (PRWEB) October 17, 2014 Medrio, a leading provider of eClinical Software as a Service (SaaS) for clinical research, announced today that Atlantic Research Group, a world class CRO helping emerging, agile biopharma firms bring new therapies to market, has joined Medrio’s Partner Program. “Atlantic Research Group is a great addition to our partner program,” says Scott Weidley,...

2014-10-17 23:02:58

RnRMarketResearch.com adds “Osteoporosis & Osteoarthritis – Pipeline Review, H2 2014” to its store. The report provides an overview of the Osteoporosis’s and Osteoarthritis’s therapeutic pipeline. Dallas, Texas (PRWEB) October 17, 2014 This report provides comprehensive information on the therapeutic development for Osteoarthritis & Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route...

2014-10-17 16:24:18

BALTIMORE, Md., Oct. 17, 2014 /PRNewswire-USNewswire/ -- The following is being released by the Center for Medical Technology Policy: The Green Park Collaborative (GPC) will bring together representatives from the FDA, public and private payers, medical device and pharmaceutical companies, as well as patient representatives, clinicians, and other experts January 12, 2015 at its first ever workshop on the comparative effectiveness and value of weight loss treatments. Participants...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.